Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,100 | 44,199 | 60,508 | 24,755 | 37,671 |
| Marketable Securities | 175,827 | 158,555 | 169,163 | 116,603 | 56,932 |
| Receivables | 1,609 | 1,786 | 1,617 | 813 | 209 |
| TOTAL | $194,810 | $207,010 | $233,870 | $144,866 | $96,478 |
| Non-Current Assets | |||||
| PPE Net | 2,954 | 2,347 | 2,155 | 1,660 | 1,212 |
| Other Non-Current Assets | 1,364 | 1,319 | 1,018 | 1,171 | 1,214 |
| TOTAL | $4,318 | $3,666 | $3,173 | $2,831 | $2,426 |
| Total Assets | $199,128 | $210,676 | $237,043 | $147,697 | $98,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 15,676 | 4,650 | 3,616 |
| Accounts payable and accrued liabilities | 8,875 | 7,769 | 8,084 | 8,818 | 7,923 |
| TOTAL | $16,917 | $21,055 | $48,524 | $43,379 | $11,697 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 10,889 | 11,786 |
| Deferred Revenues | 7,446 | 12,692 | 24,608 | 29,743 | N/A |
| Other Non-Current Liabilities | 188 | 323 | 541 | 743 | 857 |
| TOTAL | $188 | $323 | $541 | $12,341 | $12,643 |
| Total Liabilities | $17,105 | $21,378 | $49,065 | $55,720 | $24,340 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,007 | 34,995 | 34,974 | 34,956 | 25,869 |
| Common Shares | 397,654 | 397,652 | 397,307 | 294,244 | 266,425 |
| Retained earnings | -266,169 | -257,314 | -257,139 | -249,655 | -238,279 |
| Other shareholders' equity | -990 | -990 | -990 | 6,742 | -990 |
| TOTAL | $182,023 | $189,298 | $187,978 | $91,977 | $74,564 |
| Total Liabilities And Equity | $199,128 | $210,676 | $237,043 | $147,697 | $98,904 |